How It Works

TG-C is an investigational cell-based therapy, currently being studied for the treatment of knee osteoarthritis. If approved by the US Food and Drug Administration, it could become the first cell therapy in this space.

MoA_01_07.17.png

IL-10, interleukin-10; PGE2, prostaglandin E2; TGF-β1; transforming growth factor beta 1; TSP1, thrombospondin-1.

MoA_02.png

IL-10, interleukin-10; IL-1β, interleukin-1 beta; TNF-α; tumor necrosis factor alpha.